AKT1 and hepatocellular carcinoma: Moreover, Shi et al. reported that HepG2 hepatocellular carcinoma cells exhibited increased proliferation upon irisin treatment, attributed to PI3K/Akt pathway activation, highlighting potential tissue-specific responses [55] (Table 1).